NextCure, Inc. (NXTC) ownership: Top institutional holder: Squadron Capital Management LLC ($2.83M). Insider activity: Net Buyer (12 buys, 8 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Squadron Capital Management LLC | 265000.00 | $2.83M | 2026-03-31 |
| Affinity Asset Advisors, LLC | 241826.00 | $2.58M | 2026-03-31 |
| Ikarian Capital, LLC | 238303.00 | $2.51M | 2026-03-31 |
| Sofinnova Investments, Inc. | 222654.00 | $2.38M | 2026-03-31 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 176057.00 | $1.88M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 160473.00 | $1.69M | 2026-03-31 |
| Pfizer Inc | 153354.00 | $1.54M | 2026-03-31 |
| Opaleye Management Inc. | 141181.00 | $1.51M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-10 | |
| Buy | null | 2026-07-30 | |
| Buy | null | 2026-07-30 | |
| Buy | null | 2026-07-30 | |
| Buy | null | 2026-07-30 | |
| Buy | null | 2026-07-30 | |
| Buy | null | 2026-07-30 | |
| Buy | null | 2026-07-30 |
Back to NXTC overview · NXTC earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.